Evidence map›Paper›PMID 28935696›Full record

ArticleBlood2017

A genome-wide association study of LCH identifies a variant in

Erin C Peckham-Gregory, Rikhia Chakraborty, Michael E Scheurer, John W Belmont, Harshal Abhyankar, Amel G Sengal, Brooks P Scull, Olive Eckstein, Daniel J Zinn, Louisa Mayer and 6 more

Abstract readLetter
In one paragraph

Article in Blood, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Langerhans cell histiocytosis with aneurysmal bone cyst-like changes: a case-based literature review.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2023
    Review
  7. Article
  8. A Rare Convergence: Adult-Onset Langerhans Cell Histiocytosis and HIV Infection.European journal of case reports in internal medicine · 2023
    Article
  9. Histiocytic disorders.Nature reviews. Disease primers · 2021
    Review
  10. Histiocytosis.Lancet (London, England) · 2021
    Review
  11. Langerhans cell histiocytosis: Version 2021.Hematological oncology · 2021
    Review
  12. Article
  13. Langerhans-Cell Histiocytosis.The New England journal of medicine · 2018
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Erin C Peckham-GregoryTexas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX.
Rikhia ChakrabortyTexas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX.
Michael E ScheurerTexas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX.
John W BelmontDepartment of Molecular and Human Genetics, and.
Harshal AbhyankarTexas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX.
Amel G SengalTexas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX.
Brooks P ScullTexas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX.
Olive EcksteinTexas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX.
Daniel J ZinnTexas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX.
Louisa MayerTexas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX.
Albert ShihTexas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX.
Miriam MeradTisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
D Williams ParsonsTexas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX.
Kenneth L McClainTexas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX.
Philip J LupoTexas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX.
Carl E AllenTexas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX.

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Michael M Ittmann · 2007 to 2026
$73.9M
Tissue ResourceP50CA126752 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Leonid S Metelitsa · 2007 to 2026
$51.4M
PEDIATRIC ONCOLOGY CLINICAL RESEARCH TRAINING PROGRAMK12CA090433 · NCI · BAYLOR COLLEGE OF MEDICINE · PI CARL E ALLEN, Donald W. Parsons · 2002 to 2026
$18.5M
The Collaborative Genetic Study of Nicotine DependenceP01CA089392 · NCI · WASHINGTON UNIVERSITY · PI STITZEL, JERRY A · 2001 to 2012
$17.3M
RELAPSE: LINKING SCIENCE AND PRACTICEP50CA084724 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI FIORE, MICHAEL C · 1999 to 2003
$8.9M
Tobacco Dependence: Treatment and OutcomesP50DA019706 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI FIORE, MICHAEL C · 2004 to 2008
$8.6M
ERK control of Dendritic Cell Differentiation, Homeostasis and DiseaseR01CA154947 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CARL E ALLEN, MIRIAM MERAD · 2011 to 2026
$7.0M
Genome Wide Association Coordinating CenterU01HG004446 · NHGRI · UNIVERSITY OF WASHINGTON · PI WEIR, BRUCE S. · 2007 to 2011
$6.6M
LIMBIC &MEDULLARY MECH. IN COCAINE-RELATED SUDDEN DEATHR01DA006227 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MASH, DEBORAH C. · 1990 to 2012
$3.7M
Methods for high-resolution analysis of genetic effects on gene expressionR01MH101814 · NIMH · UNIVERSITY OF GENEVA · PI BUSTAMANTE, CARLOS DANIEL, DERMITZAKIS, EMMANOUIL · 2013 to 2016
$2.3M
Harnessing GTEx to Create Transcriptome Knowledge and Inform Disease BiologyR01MH101820 · NIMH · UNIVERSITY OF CHICAGO · PI COX, NANCY J, NICOLAE, DAN LIVIU · 2013 to 2015
$2.3M
Identification and validation of cell specific eQTLs by Bayesian modelingR01MH101822 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI BROWN, CHRISTOPHER DAVID, ENGELHARDT, BARBARA · 2013 to 2016
$1.9M
NCI NIH HHS HHSN261200800001ENCI NIH HHS K12 CA090433NCI NIH HHS P01 CA089392NCI NIH HHS P30 CA125123NCI NIH HHS P50 CA084724NCI NIH HHS P50 CA126752NCI NIH HHS R01 CA154489NCI NIH HHS R01 CA154947NCI NIH HHS R25 CA160078NHGRI NIH HHS HHSN268200782096CNHGRI NIH HHS U01 HG004446NHLBI NIH HHS HHSN268201000029CNICHD NIH HHS R01 HD052740NIDA NIH HHS P50 DA019706NIDA NIH HHS R01 DA006227NIMH NIH HHS R01 MH090936NIMH NIH HHS R01 MH090937NIMH NIH HHS R01 MH090941NIMH NIH HHS R01 MH090948NIMH NIH HHS R01 MH090951NIMH NIH HHS R01 MH101782NIMH NIH HHS R01 MH101810NIMH NIH HHS R01 MH101814NIMH NIH HHS R01 MH101820NIMH NIH HHS R01 MH101822NIMH NIH HHS R01 MH101825
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic Predisposition to DiseaseGerm-Line MutationCase-Control StudiesFamilyGenome-Wide Association StudyHistiocytosis, Langerhans-CellHumansPolymorphism, Single NucleotideSmad6 ProteinSmad6 ProteinSMAD6 protein, human

Identifiers

PMID28935696
PMCPMC5691246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.